Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
348.03
+1.16 (+0.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about United Therapeutic
< Previous
1
2
3
Next >
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
July 31, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
July 24, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
July 10, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
June 27, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
May 01, 2024
From
United Therapeutics Corporation
Via
Business Wire
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
April 26, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
April 24, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
April 16, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
March 26, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
March 25, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
March 05, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Commences Litigation to Ensure Fairness in the Drug Review Process
February 21, 2024
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 29, 2023
From
United Therapeutics Corporation
Via
Business Wire
Liquidia: Court victory the awakening of an industry giant?
December 27, 2023
Liquidia's stock surged after an enormous court win against United Therapeutics, accompanied by analyst upgrades and insider buying.
Via
MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
December 13, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
December 12, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
December 07, 2023
From
United Therapeutics Corporation
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)
November 13, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
November 01, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
October 31, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
October 31, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023
October 25, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs
September 22, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report
September 12, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 01, 2023
From
United Therapeutics Corporation
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.